Log in to save to my catalogue

A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein bind...

A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein bind...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9518f5d64f6644dfa69bfe01bd7690cd

A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors

About this item

Full title

A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors

Publisher

Frontiers Media S.A

Journal title

Frontiers in behavioral neuroscience, 2024-12, Vol.18, p.1347543

Language

English

Formats

Publication information

Publisher

Frontiers Media S.A

More information

Scope and Contents

Contents

Anxiety disorders are among the most common mental illnesses in the US. An estimated 31.1% of U.S. adults experience any anxiety disorder at some time in their lives. Understanding some of the molecular underpinnings of anxiety could lead to improved treatments over current strategies focusing on symptom relief rather than root causes. One signific...

Alternative Titles

Full title

A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9518f5d64f6644dfa69bfe01bd7690cd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9518f5d64f6644dfa69bfe01bd7690cd

Other Identifiers

ISSN

1662-5153

E-ISSN

1662-5153

DOI

10.3389/fnbeh.2024.1347543

How to access this item